Details for New Drug Application (NDA): 209727
✉ Email this page to a colleague
The generic ingredient in PREDNISONE is prednisone. There are sixteen drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the prednisone profile page.
Summary for 209727
Tradename: | PREDNISONE |
Applicant: | Strides Pharma |
Ingredient: | prednisone |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 209727
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 209727
Suppliers and Packaging for NDA: 209727
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PREDNISONE | prednisone | TABLET;ORAL | 209727 | ANDA | QPharma Inc | 42708-186 | 42708-186-21 | 21 TABLET in 1 BOTTLE, PLASTIC (42708-186-21) |
PREDNISONE | prednisone | TABLET;ORAL | 209727 | ANDA | A-S Medication Solutions | 50090-5814 | 50090-5814-0 | 21 TABLET in 1 BOTTLE (50090-5814-0) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2.5MG | ||||
Approval Date: | Nov 20, 2020 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | Nov 20, 2020 | TE: | AB | RLD: | No |
Complete Access Available with Subscription